Retraction notice to “MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14” [Biomed. Pharmacother. 98 (2018) 636–642, (S0753332217345006), (10.1016/j.biopha.2017.12.044)]

Qi Li; Lei Zhou; Maode Wang; Ning Wang; Chuankun Li; Jia Wang; Lei Qi

doi:10.1016/j.biopha.2024.116383

Retraction notice to “MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14” [Biomed. Pharmacother. 98 (2018) 636–642, (S0753332217345006), (10.1016/j.biopha.2017.12.044)]

Qi Li
, Lei Zhou
, Maode Wang
, Ning Wang
, Chuankun Li
, Jia Wang
, Lei Qi

The First Affiliated Hospital of Xi’an Jiaotong University
Guangren Hospital of Xi'an Jiaotong University

Research output: Contribution to journal › Comment/debate

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the Authors and the Editor-in-Chief. The Authors contacted the Journal, requesting a retraction but not giving any reasons. While assessing the matter, comments relating to duplications in Figures 2 and 6 were found on PubPeer: https://pubpeer.com/publications/0C15527DFD3AEFEA5A46FBF9F62D2D#1, and the Journal's own analysis found several duplications in the manuscript. The Journal asked for a full explanation from the Authors. The Authors did not respond, and the Editor-in-Chief decided to retract.

Original language	English
Article number	116383
Journal	Biomedicine and Pharmacotherapy
Volume	173
DOIs	https://doi.org/10.1016/j.biopha.2024.116383
State	Published - Apr 2024
Externally published	Yes

Access to Document

10.1016/j.biopha.2024.116383

Fingerprint

Dive into the research topics of 'Retraction notice to “MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14” [Biomed. Pharmacother. 98 (2018) 636–642, (S0753332217345006), (10.1016/j.biopha.2017.12.044)]'. Together they form a unique fingerprint.

Cite this

Li, Q., Zhou, L., Wang, M., Wang, N., Li, C., Wang, J., & Qi, L. (2024). Retraction notice to “MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14” [Biomed. Pharmacother. 98 (2018) 636–642, (S0753332217345006), (10.1016/j.biopha.2017.12.044)]. Biomedicine and Pharmacotherapy, 173, Article 116383. https://doi.org/10.1016/j.biopha.2024.116383

@article{dd0e353e1b4c468da07ceb7771382667,

title = "Retraction notice to {\textquotedblleft}MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14{\textquotedblright} [Biomed. Pharmacother. 98 (2018) 636{\textendash}642, (S0753332217345006), (10.1016/j.biopha.2017.12.044)]",

abstract = "This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the Authors and the Editor-in-Chief. The Authors contacted the Journal, requesting a retraction but not giving any reasons. While assessing the matter, comments relating to duplications in Figures 2 and 6 were found on PubPeer: https://pubpeer.com/publications/0C15527DFD3AEFEA5A46FBF9F62D2D\#1, and the Journal's own analysis found several duplications in the manuscript. The Journal asked for a full explanation from the Authors. The Authors did not respond, and the Editor-in-Chief decided to retract.",

author = "Qi Li and Lei Zhou and Maode Wang and Ning Wang and Chuankun Li and Jia Wang and Lei Qi",

note = "Publisher Copyright: {\textcopyright} 2024 Elsevier Masson SAS",

year = "2024",

month = apr,

doi = "10.1016/j.biopha.2024.116383",

language = "英语",

volume = "173",

journal = "Biomedicine and Pharmacotherapy",

issn = "0753-3322",

publisher = "Elsevier Masson s.r.l.",

}

Li, Q, Zhou, L, Wang, M, Wang, N, Li, C, Wang, J & Qi, L 2024, 'Retraction notice to “MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14” [Biomed. Pharmacother. 98 (2018) 636–642, (S0753332217345006), (10.1016/j.biopha.2017.12.044)]', Biomedicine and Pharmacotherapy, vol. 173, 116383. https://doi.org/10.1016/j.biopha.2024.116383

Retraction notice to “MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14” [Biomed. Pharmacother. 98 (2018) 636–642, (S0753332217345006), (10.1016/j.biopha.2017.12.044)]. / Li, Qi; Zhou, Lei; Wang, Maode et al.
In: Biomedicine and Pharmacotherapy, Vol. 173, 116383, 04.2024.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Retraction notice to “MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14” [Biomed. Pharmacother. 98 (2018) 636–642, (S0753332217345006), (10.1016/j.biopha.2017.12.044)]

AU - Li, Qi

AU - Zhou, Lei

AU - Wang, Maode

AU - Wang, Ning

AU - Li, Chuankun

AU - Wang, Jia

AU - Qi, Lei

PY - 2024/4

Y1 - 2024/4

N2 - This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the Authors and the Editor-in-Chief. The Authors contacted the Journal, requesting a retraction but not giving any reasons. While assessing the matter, comments relating to duplications in Figures 2 and 6 were found on PubPeer: https://pubpeer.com/publications/0C15527DFD3AEFEA5A46FBF9F62D2D#1, and the Journal's own analysis found several duplications in the manuscript. The Journal asked for a full explanation from the Authors. The Authors did not respond, and the Editor-in-Chief decided to retract.

AB - This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the Authors and the Editor-in-Chief. The Authors contacted the Journal, requesting a retraction but not giving any reasons. While assessing the matter, comments relating to duplications in Figures 2 and 6 were found on PubPeer: https://pubpeer.com/publications/0C15527DFD3AEFEA5A46FBF9F62D2D#1, and the Journal's own analysis found several duplications in the manuscript. The Journal asked for a full explanation from the Authors. The Authors did not respond, and the Editor-in-Chief decided to retract.

UR - https://www.scopus.com/pages/publications/85187382017

U2 - 10.1016/j.biopha.2024.116383

DO - 10.1016/j.biopha.2024.116383

M3 - 评论/辩论

C2 - 38453578

AN - SCOPUS:85187382017

SN - 0753-3322

VL - 173

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

M1 - 116383

ER -

Li Q, Zhou L, Wang M, Wang N, Li C, Wang J et al. Retraction notice to “MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14” [Biomed. Pharmacother. 98 (2018) 636–642, (S0753332217345006), (10.1016/j.biopha.2017.12.044)]. Biomedicine and Pharmacotherapy. 2024 Apr;173:116383. doi: 10.1016/j.biopha.2024.116383

Retraction notice to “MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14” [Biomed. Pharmacother. 98 (2018) 636–642, (S0753332217345006), (10.1016/j.biopha.2017.12.044)]

Abstract

Access to Document

Other files and links

Fingerprint

Cite this